ArticleFood science & nutrition2025
Bacteroides, Metabolites, and Lymphocytes: A Triad of Biomarkers in Small Intestinal Bacterial Overgrowth.
Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Bacteroides, Metabolites, and Lymphocytes: A Triad of Biomarkers in Small Intestinal Bacterial Overgrowth.Food science & nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The purpose of this study was to investigate the clinical characteristics of small intestinal bacterial overgrowth (SIBO) and analyze its relationship with changes in intestinal microbiota and metabolites. The study included patients from Beijing Shijitan Hospital (Feb 2021-Nov 2023) who underwent hydrogen-methane breath tests, hematological tests, and completed questionnaires. Baseline characteristics of SIBO patients were analyzed using descriptive statistics and independent t-tests. Logistic regression and Receiver Operating Characteristic (ROC) curve analysis identified potential SIBO predictors. Chi-square tests assessed the association between SIBO and symptoms. Stool samples from 29 patients underwent 16S rRNA sequencing to analyze gut microbiota and metabolites. Then we explored links between microbiota, metabolites, symptoms, and serum markers. 405 persons in all completed the hydrogen methane breath test, of whom 109 (26.91%) were in the SIBO- and 296 (73.09%) were in the SIBO+. No significant differences were observed between the SIBO+ and SIBO- groups in terms of gender, age, or BMI. However, lymphocyte counts were significantly different between the groups, with lymphocyte count proving to be a better predictor of SIBO in middle-aged and elderly non-obese men. SIBO was significantly associated with diarrhea and acid reflux symptoms. 16S rRNA sequencing of stool samples from 29 patients revealed that
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.